Research and Development

Showing 15 posts of 9603 posts found.

screen_shot_2011-11-24_at_09

Professor Sir Michael Rawlins reappointed as NICE chairman

November 24, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Rawlins

The National Institute for Health and Clinical Excellence (NICE) has reappointed Professor Sir Michael Rawlins as NICE chairman for a …

Big pharma counts cost of R&D decline

November 23, 2011 Research and Development Deloitte, GSK, IIR, R&D productivity

Leading pharma firms are getting around 30% less on their investments in research and development compared to last year, according …

Pharmalink elects Anders Wiklund as its new board chairman

November 23, 2011 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Pharmalink

Swedish speciality firm Pharmalink AB has elected Anders Wiklund to serve as its new chairman of the board. In addition …

Pancreatic cancer sees lowest improvement in cancer survival

November 23, 2011 Medical Communications, Research and Development Cancer, Macmillan, pancreatic

A new cancer survival study shows that pancreatic cancer continues to have one of the worst mortality rates.  The study …

Changes to the EMA’s registration process for SMEs

November 22, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Medicines Agency (EMA) has recently made changes to its process for the registration of micro, small or medium-sized …

AstraZeneca appoints two new senior leaders in its Americas division

November 22, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca

AstraZeneca has appointed Rich Fante as regional vice president of the Americas, and Marion McCourt as chief operating officer of …

Thomas Thorp promoted to senior director of corporate affairs at Lilly UK

November 22, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing lilly

Thomas Thorp has been promoted to senior director of corporate affairs at Lilly UK. Thorp will now lead all of …
Eylea picture

Lucentis rival gains US approval

November 22, 2011 Research and Development, Sales and Marketing Bayer, Eylea, Lucentis, Novartis, Regeneron, Roche

A rival to Roche and Novartis’ drug Lucentis has received FDA approval for a common form of eye disease. Eylea …

Gilead aims for hep C lead with Pharmasset acquisition

November 22, 2011 Research and Development Gilead, HCV, Pharmasset, Victrelis, hepatitis C

Gilead Sciences is to buy Pharmasset for $11 billion in a bid to become a leader in hepatitis C treatment.The …
Willetts opens the new Celgene headquarters

Celgene opens new headquarters in UK

November 21, 2011 Research and Development, Sales and Marketing Celgene

Celgene has opened new UK headquarters in London as its haematology-based business expands. The firm says it has decided to …

Update on the planned consolidation of UK medicines legislation

November 21, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Earlier this year we reported on progress in the consolidation of the UK medicines legislation and that the Medicines and …

EMA accepts submission of Pfizer’s new arthritis drug

November 21, 2011 Research and Development, Sales and Marketing EMA, Pfizer, tofacitinib

The European Medicines Agency has accepted Pfizer’s arthritis drug tofacitinib for review.Tofacitinib is a novel, oral JAK inhibitor being studied …

Andreas Pott appointed deputy executive director of European Medicines Agency

November 21, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EMA, Europe

The European Medicines Agency’s new executive director Guido Rasi has appointed Andreas Pott as deputy executive director. Pott’s appointment follows …
Avastin picture

FDA pulls Roche’s Avastin for breast cancer

November 21, 2011 Research and Development, Sales and Marketing FDA, Roche, avastin

The FDA has pulled Avastin’s breast cancer licence in the US after the drug failed to prove its safety and …
The Gateway to Local Adoption Series

Latest content